A photo of Kasiani Myers.

Kasiani C. Myers, MD

  • Member, Division of Bone Marrow Transplantation and Immune Deficiency
  • Associate Professor, UC Department of Pediatrics



I always wanted to be a physician, and specifically a pediatrician. My father is an adult subspecialist, but I was drawn to the care of medically complex children. Now, I enjoy being the bridge between basic research and the clinic.

In my clinical practice, I specialize in treating patients with bone marrow failure and hematopoietic stem cell transplant for non-malignant diseases, with a special emphasis on Shwachman Diamond syndrome and dyskeratosis congenita. My research interests focus on translational and clinical studies in leukemogenesis and bone marrow failure related to these two conditions. I also study the complications of stem cell transplants, including bronchiolitis obliterans and fertility preservation.

I decided to pursue my research interests after my experience as a resident physician and fellow at Cincinnati Children’s. I enjoyed getting to know my patients on the bone marrow transplant and hematology/oncology units. Plus, I was mentored by two of the world’s foremost experts in the field, Dr. Stella Davies and Dr. Richard Harris, right here at Cincinnati Children’s.

After I completed my postdoctoral training, I joined the faculty of the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children’s within the UC Department of Pediatrics. Now, in addition to clinical work and research, I serve as the co-director of the North American Shwachman Diamond Syndrome Registry.

BS: University of Michigan, Ann Arbor, MI, 2000.

MD: Case Western Reserve University, Cleveland, OH, 2004.

Post-Doctoral: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

Certification: Pediatrics, 2007.

Services and Specialties

Cancer and Blood Diseases, Bone Marrow Transplantation BMT, Fanconi Anemia, Fertility Preservation, Rare Lung Diseases

Research Areas

Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases

Additional Languages

French, Greek

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information


Pre-transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients. Sarkar, N; Myers, KC; Lane, A; Davies, SM; Benoit, SW. Pediatric Blood and Cancer. 2024; e30853.

Posttransplant complications in patients with marrow failure syndromes: are we improving long-term outcomes?. Hudda, Z; Myers, KC. Hematology-American Society of Hematology Education Program. 2023; 2023:141-148.

No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. Knight, TE; Ahn, KW; Hebert, KM; Atshan, R; Wall, DA; Chiengthong, K; Lund, TC; Prestidge, T; Rangarajan, HG; Dvorak, CC; et al. Bone Marrow Transplantation. 2023; 58:1390-1393.

Lymphoid Malignancies in Shwachman-Diamond Syndrome: Incidence, Clinical Features, and Outcomes from the North American SDS Registry. Reed, HD; Do, H; Weller, E; Farrar, JE; Gamper, C; Lau, BW; Pommert, L; Atkinson, I; Joos, M; Loveless, S; et al. Blood. 2023; 142:5662.

Hematopoietic Stem Cell Transplantation for Fanconi Anemia: Outcome and Prognostic Factors for Survival and Subsequent Neoplasms. Rotz, SJ; Heim, M; Kim, S; Gennery, A; Georges, GE; Myers, K; Broglie, L; Eissa, H. Blood. 2023; 142:948.

Human Hematopoietic Stem Cells Have Altered Mitochondrial Activity after Stem Cell Transplantation. Coppola, T; Perrone, O; Batram, J; Nasr, W; Treichel, S; Xu, J; Myers, K; Filippi, M. Blood. 2023; 142:3430.

Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation. Koo, J; Ziady, AG; Reynaud, D; Abdullah, S; Luebbering, N; Kahn, S; Langenberg, L; Strecker, L; Lake, K; Dandoy, CE; et al. Transplantation and cellular therapy. 2023; 29:704.e1-704.e8.

Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant. Koo, J; Grom-Mansencal, I; Howell, JC; Rios, JM; Mehta, PA; Davies, SM; Myers, KC. Haematologica: the hematology journal. 2023; 108:2358-2368.

Optimized vitamin D repletion with oral thin film cholecalciferol in patients undergoing stem cell transplant. Bartlett, AL; Zhang, G; Wallace, G; McLean, S; Myers, KC; Teusink-Cross, A; Taggart, C; Patel, B; Davidson, R; Davies, SM; et al. Blood Advances. 2023; 7:4555-4562.

Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors. Knight, TE; Ahn, KW; Hebert, KM; Atshan, R; Wall, DA; Chiengthong, K; Rotz, SJ; Fraint, E; Rangarajan, HG; Auletta, JJ; et al. Transplantation and cellular therapy. 2023; 29:380.e1-380.e9.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Overall Patient Rating